Page 39 - Sanket Koul

NHM helped increase central govt's spending on healthcare: CSEP-CPR study

Researchers add that this was largely due to the launch and subsequent expansion of spending on NHM in the first eight years

Pharmaceutical companies prepare to comply with ethical marketing code

The UCPMP aims to curb the unethical marketing of drugs and ban medical representatives from using inducements to access healthcare professionals

Health ministry's mental health helpline crosses 1 mn calls since inception

The programme aims to enhance nationwide mental health service delivery, offering multi-language support and facilitating communication between callers and mental health professionals

Fortis plans to add 700 beds in FY25: MD & CEO Ashutosh Raghuvanshi

Raghuvanshi provides an overview of the company's FY24 performance and expansion plans for FY25

Vivek Vihar hospital blaze incident ignites fire safety review in Delhi

Investigation yet to pinpoint cause 48 hours on

Experts flag need to stop OTC sale of antibiotics, spread awareness

The study adds that an estimated 7.7 million die in LMICs due to bacterial infections, of which almost five million deaths are due to AMR bacteria

Torrent Pharma Q4FY24 results: Net profit up 57%, revenue rises 10%

At an operational level, Torrent Pharma's earnings before interest, tax, depreciation and amortisation (Ebitda) increased by 21 per cent to Rs 883 crore

Fortis Healthcare Q4 results: Net profits up 46.9%, revenue rises 8.7%

The company's revenue from operations rose to Rs 1,786 crore in Q4 FY24, an 8.7 per cent Y-o-Y rise from Rs 1,643 crore reported in Q4 FY23

Yatharth Hospitals Q4 result: Net profit up 121%, revenue rises 24%

The company also announced the commencement of operations at their newly acquired hospital in Faridabad, strengthening its presence in the Delhi NCR market

Emcure, Gennova settle legal dispute with US-based HDT Bio, sign agreement

Litigation before courts in the US and arbitral tribunal in London settled, two sides say

Looking to add around 1,000 beds by early FY26: Max Healthcare CMD Soi

Soi gives an overview of the company's performance in FY24 and its expansion plans for FY25

State regulators asked to withdraw marketing of cancer drug Olaparib

Manufacturer AstraZeneca Pharma India says its study shows drug may have detrimental effect

Medical device bodies welcome CDSCO order on self-reporting adverse effects

The drug regulator stated that medical device manufacturers need to take appropriate action for timely reporting of adverse events related to medical devices to MvPI

KKR acquires minority stake in Healthcare BPO firm Infinx for Rs 1,250 cr

Founded in 2012, Infinx is a provider of innovative, data-driven revenue cycle management solutions for the healthcare sector, with a particular focus on the US market

ICMR distances itself from BHU study on Covaxin, calls it 'poorly designed'

Bharat Biotech had then rebuked the BHU study, saying that its indigenously developed Covid vaccine Covaxin has shown an 'excellent safety track record' in various studies

Vulnerable population: Rising heat on public health infrastructure

Heat preparedness Measures for health care sector

Medical device companies get a three-month extension for licences

The step comes after several medical device associations and stakeholders had sent representations to the drug regulator, asking for an extension to adhere to the new licensing regulations

Medanta Hospitals Q4 results: Net profit up 25%, revenue rises 14.3%

The hospital operator's revenue from operations rose to Rs 808.6 crore in Q4 FY24, a 14.3 per cent rise from Rs 707 crore in Q4 FY23

Indian pharma firms supplied 47% of all generic prescriptions in US in 2022

Indian pharmaceutical companies also accounted for a lower but important share of biosimilar production, manufacturing 15 per cent of biosimilar volume used by US patients in 2022

Diabetes to infections: NPPA slashes retail prices of 41 essential drugs

Prices of essential drugs such as dapagliflozin metformin hydrochloride, used for lowering blood glucose levels by decreasing glucose production in the liver, have been fixed at Rs 16 per tablet